MetabolomicsWorkbenchapplication/xmlhttp://www.metabolomicsworkbench.org/rest/study/study_id/ST002346/mwtabprimaryOK200MetabolomicsMass SpectrometryESIHomo Sapienshttp://www.metabolomicsworkbench.org/data/DRCCMetadata.php?Mode=Study&StudyID=ST002346Genotype:Pex11b-KOGenotype:Drp1-KOGenotype:Control4Genotype:DLP1mutGenotype:dPEX11bGenotype:dNME3Genotype:Control1Genotype:Control3Genotype:Wild-TypeGenotype:Control2Cultured CellsKyushu universityReversed phase POSITIVE ION MODE. Reversed phase POSITIVE ION MODE.MetabolomicsWorkbenchPE 14:0/18:2PC 18:1/22:4PC 18:1/22:5PE 16:0/18:2PE 16:0/18:0PE 16:0/18:1aPC 16:0/16:0pPE 18:1/18:1pPE 18:1/18:2aPC 16:0/16:1PE 18:0/18:1pPE 18:0/18:2PE 18:0/18:2pPE 16:0/18:1pPE 18:0/18:1PE 18:0/18:3PC 18:0/22:4PC 18:0/22:3pPE 16:0/18:2PC 16:0/22:2PC 16:0/22:1PE 18:1/18:2PE 18:1/18:1PE 16:1/18:2pPE 18:1/22:4pPE 18:1/22:5pPE 18:1/22:6PE 16:0/22:6PE 16:0/22:4PE 18:0/22:3PE 18:0/22:4PE 18:0/22:5PE 18:0/22:6pPE 18:1/22:3PC 16:1/22:6PC 16:1/22:5PC 18:1/22:6aPC 18:1/22:4aPC 18:1/22:6aPC 18:1/22:5PC 18:0/18:3PC 18:0/18:2PC 18:0/18:1PC 18:0/18:0PC 16:0/16:0PE 16:1/22:6PC 16:0/16:1PE 18:0/22:1PE 18:0/22:2aPC 18:0/20:4aPC 18:0/20:1PC 16:1/18:2PC 16:1/18:1aPC 18:1/18:1PC 16:0/20:5PC 18:0/22:6PC 18:0/22:5PC 14:0/22:6aPC 16:0/22:4pPE 16:0/20:2aPC 16:0/22:6pPE 16:0/20:1pPE 18:0/22:6pPE 16:0/20:4pPE 16:0/20:3pPE 18:0/22:5pPE 18:0/22:4pPE 16:0/20:5PE 18:1/20:3PE 18:1/20:2PE 18:1/20:5PE 18:1/20:4PC 18:1/20:5PC 16:1/20:3PC 18:1/20:1PC 18:1/20:2PC 16:1/20:4PC 18:1/20:3aPC 18:0/18:1pPE 18:1/16:0PE 16:0/16:0pPE 18:1/16:1PE 16:0/16:1aPC 16:0/18:1aPC 16:0/18:2aPC 16:0/18:0pPE 18:0/16:1pPE 18:0/16:0pPE 16:0/16:1pPE 16:0/16:0PC 18:0/20:5PC 18:0/20:4PC 16:0/20:4PC 18:0/20:3PC 16:0/20:3PC 18:0/20:0PE 16:0/20:5PE 16:0/20:3PE 16:0/20:4PE 18:0/20:5pPE 18:1/20:1pPE 18:1/20:2pPE 18:1/20:3pPE 18:1/20:4pPE 18:1/20:5aPC 18:1/20:1aPC 18:1/20:4PC 16:0/18:0PC 16:0/18:1PC 16:0/18:2PE 18:1/22:5PE 18:1/22:4PC 14:0/16:0PC 14:0/16:1PE 18:1/22:6PE 18:0/20:1PE 18:0/20:2PE 18:0/20:3PE 18:0/20:4aPC 16:0/20:3PC 18:1/18:2PC 18:1/18:1PC 16:1/16:1PC 14:0/20:4PC 16:0/22:4PC 16:0/22:3PC 16:0/22:6PC 16:0/22:5aPC 16:0/20:4aPC 16:0/20:5aPC 18:0/22:4pPE 18:0/20:4pPE 18:0/20:3aPC 18:0/22:6pPE 18:0/20:2pPE 18:0/20:1pPE 16:0/22:4pPE 16:0/22:3pPE 18:0/20:5pPE 16:0/22:6pPE 16:0/22:5PE 18:1/22:2peroxisome proliferation., Lipidomes, study, atypia, peroxisome division, Lipidome, atypical, defective, aberrant, Cell, Lipidomicbackward, reversed., reversedfalseLipidomics study of the cells defective in peroxisome divisionST0023469606